Molecular simulation aspects of amyloid peptides at membrane interface
Yonglan Liu1, Baiping Ren2, Yanxian Zhang2
1Hunan Key Laboratory of Biomedical Nanomaterials and Devices, College of Life Science and Chemistry, Hunan University of Technology, Zhuzhou 412007, PR China; Department of Chemical and Biomolecular Engineering, The University of Akron, Akron, OH 44325, United States.
Computational studies reveal how amyloid peptides interact with cell membranes, crucial for understanding protein-misfolding diseases and developing new treatments. This review highlights key mechanisms and future research directions.
Area of Science:
- Biophysics
- Computational Biology
- Neuroscience
Background:
- Amyloid peptides interact with cell membranes, impacting membrane integrity and function.
- Understanding these interactions is vital for deciphering amyloid aggregation and toxicity in diseases.
- Cell membrane interfaces are critical sites for protein aggregation and misfolding.
Purpose of the Study:
- To review recent computational studies on amyloid peptides at model cell membranes.
- To discuss diverse mechanisms of amyloid peptide action on cell membranes.
- To identify future research directions for protein-misfolding diseases.
Main Methods:
- Review of computational studies.
- Analysis of molecular-level structure and dynamics.
- Examination of interactions at various length and timescales.
Main Results:
- Different computational techniques reveal various mechanisms of amyloid peptide interaction with membranes.
- Insights into how amyloid peptides affect membrane integrity and function.
- Identification of key factors influencing amyloid aggregation and toxicity at the membrane interface.
Conclusions:
- Computational approaches provide critical molecular insights into amyloid-membrane interactions.
- Further research is needed to fully understand the role of these interactions in protein-misfolding diseases.
- This review offers perspectives for future studies to bridge bench-to-bedside applications.
More Related Videos
15:04Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
06:34A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation
Published on: March 27, 2017
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Peptide Bonds
Molecular Models
Protein-protein Interfaces
Protein-Protein Interfaces
